Erythropoietin, uncertainty principle and cancer related anaemia.
Interesting analysis -additonal evidence supporting what has now become the standard practice in the oncology community. – Patricia Ford
Recombinant human erythropoietin in pediatric oncology: a review.
Important to attempt review, but too much variability in studies to form meaningful conclusion. – Patricia Ford
The clinical value of erythropoietin in patients with cancer.
This is a good review of cancer- and chemotherapy-related anemia and its treatment with epoetin alfa. However, the review seems a bit negative regarding epoetin relative to blood transfusion when treating anemia. Initial responses can occur in two weeks, not two months. It is true that response prediction has been difficult, but 2/3 of patients […]
